Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-03-03 Sale | 2023-03-07 2:04 pm | Vir Biotechnology Inc. | VIR | Friedl-Naderer Johanna EVP & Chief Operating Officer | 1,482 | $22.82 | $33,819 | 148,518 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-12-04 Option Award | 2024-12-06 4:05 pm | N/A 2034-12-03 | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 98,100 | $0 | 156,500 (Direct) | View |
2024-09-03 Option Award | 2024-09-03 6:16 pm | N/A 2034-09-02 | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 243,700 | $0 | 243,700 (Direct) | View |
2023-02-22 Option Award | 2023-02-24 8:27 pm | N/A 2033-02-21 | Vir Biotechnology Inc. | VIR | Friedl-Naderer Johanna EVP & Chief Operating Officer | 130,000 | $0 | 220,000 (Direct) | View |
2022-03-02 Option Award | 2022-03-08 11:35 am | N/A 2032-03-01 | Vir Biotechnology Inc. | VIR | Friedl-Naderer Johanna Chief Business Officer, Global | 135,000 | $0 | 135,000 (Direct) | View |